NCT04291352View on ClinicalTrials.gov

Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2025

Conditions
Thalassemia Major
Interventions
DIETARY_SUPPLEMENT

Taurine

675mg taurine four times daily

OTHER

Placebo

placebo four times daily

Trial Locations (1)

M5G 2C4

RECRUITING

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER